Ranbaxy seeks India test on drug developed with GSK

MUMBAI, Oct 13 (Reuters) - India's Ranbaxy Laboratories Ltd (RANB.BO) said on Monday it has sought permission from Indian regulators to conduct initial-stage human clinical trials for an experimental respiratory inflammation drug it is developing with GlaxoSmithKline (GSK.L).

Under the Ranbaxy-GSK research and development collaboration, which was initiated in 2003 and expanded in 2007, Ranbaxy could receive over $100 million in potential milestone payments.

A Ranbaxy spokesman declined to comment on whether the company was getting any milestone payment for this particular move. (Reporting by Ami Shah and Bharghavi Nagaraju; Editing by John Mair)